You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapse ALL

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ACUTE LYMPHOBLASTIC LEUKEMIA Trial (Inotuzumab ozogamicin, ALLR3)

Not yet recruiting
  • ACUTE LYMPHOBLASTIC LEUKEMIA
  • (no location specified)
Feb 17, 2023

CD19+ Relapse/Refractory B-ALL Trial in Beijing (CAR-T-19 Cells)

Recruiting
  • CD19+ Relapse/Refractory B-ALL
  • CAR-T-19 Cells
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Feb 26, 2022

Copaxone Subcutaneous Injection Syringe Special Drug Use-Result

Recruiting
  • Multiple Sclerosis
  • Glatiramer acetate
  • Tokyo, Japan
    Takeda selected site
Jan 12, 2022

T-cell Acute Lymphoblastic Leukemia, T-lymphoblastic Lymphoma Trial in Kunming (Target CD7 CAR-T cells)

Withdrawn
  • T-cell Acute Lymphoblastic Leukemia
  • T-lymphoblastic Lymphoma
  • Target CD7 CAR-T cells
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Nov 23, 2022

ALL, Childhood B-Cell, Acute Lymphoid Leukemia Relapse, Acute Lymphocytic Leukemia Refractory Trial (Tafasitamab)

Not yet recruiting
  • ALL, Childhood B-Cell
  • +2 more
  • Tafasitamab
  • (no location specified)
Nov 25, 2022

Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALL, Infants With Very High Risk KMT2A B-ALL, Patients With CNS

Active, not recruiting
  • Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALL
  • +2 more
  • Murine CART19
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jan 11, 2022

Indian Children With Acute Lymphoblastic Leukemia

Not yet recruiting
  • ALL, Childhood
  • +7 more
    • New Delhi, India
    • +1 more
    Aug 22, 2022

    Tumor Tissue Samples From Young Acute Lymphoblastic Leukemia

    Completed
    • Childhood Acute Lymphoblastic Leukemia in Remission
    • Recurrent Childhood Acute Lymphoblastic Leukemia
    • Laboratory Biomarker Analysis
    • Philadelphia, Pennsylvania
      Childrens Oncology Group
    Aug 12, 2022

    Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +5 more
    • CD19 specific Chimeric Antigen Receptor T Cell
    • Columbus, Ohio
      Nationwide Children's Hospital
    Mar 9, 2023

    Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia, Refractory, Pediatric ALL Trial in Memphis (biological,

    Recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +2 more
    • CD19-CAR(Mem) T-cells
    • +5 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Aug 5, 2022

    Relapse, Advanced Malignant Tumor, Non Small Cell Lung Cancer Trial in India (AUR106)

    Not yet recruiting
    • Relapse
    • +7 more
    • Visakhapatnam, Andhra Pradesh, India
    • +5 more
    May 7, 2023

    Purpura, Thrombocytopenic, Idiopathic Trial in Beijing (all-trans retinoic acid, Eltrombopag)

    Not yet recruiting
    • Purpura, Thrombocytopenic, Idiopathic
    • Beijing, Beijing, China
      Peking University Insititute of Hematology, Peking University Pe
    Jun 25, 2022

    Philadelphia-Positive ALL, Acute Lymphoblastic Leukemia, in Relapse Trial in Italy (Ponatinib)

    Recruiting
    • Philadelphia-Positive ALL
    • Acute Lymphoblastic Leukemia, in Relapse
    • Ancona, Italy
    • +21 more
    Jan 3, 2022

    Acute Lymphoblastic Leukemia, in Relapse Trial in Bergamo, Monza (CARCIK-CD19)

    Active, not recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • CARCIK-CD19
    • Bergamo, BG, Italy
    • +1 more
    Feb 3, 2022

    Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Acute Myeloid Leukemia Trial in United States

    Recruiting
    • Refractory Acute Myeloid Leukemia
    • +4 more
    • CD371-YSNVZ-IL18 CAR T cells
    • Basking Ridge, New Jersey
    • +6 more
    Aug 29, 2023

    B-precursor Acute Lymphoblastic Leukemia, ALL, GNR-084 Trial in Moscow, Saint Petersburg (GNR-084, 0.01 ng/kg, GNR-084, 0.1

    Recruiting
    • B-precursor Acute Lymphoblastic Leukemia
    • +2 more
    • GNR-084, 0.01 ng/kg
    • +5 more
    • Moscow, Russian Federation
    • +2 more
    Oct 25, 2021

    Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoblastic Leukemia Trial in Wuhan (pCAR-19B cells)

    Recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • Refractory Acute Lymphoblastic Leukemia
    • pCAR-19B cells
    • Wuhan, Hubei, China
      Tongji Hospital affiliated to Tongji Medical College of Huazhong
    May 12, 2021

    Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia

    Recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +5 more
    • CAR-20/19-T cells (1 x 10^5 CAR-20/19-T cells/kg)
    • +4 more
    • Milwaukee, Wisconsin
      Medical College of Wisconsin
    Sep 22, 2022

    Immune Thrombocytopenia Trial in Beijing (Rituximab, All-trans retinoic acid)

    Active, not recruiting
    • Immune Thrombocytopenia
    • Beijing, Beijing, China
    • +3 more
    Jan 16, 2021

    Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Aichi (Nilotinib)

    Completed
    • Chronic Myelogenous Leukemia
    • Acute Lymphoblastic Leukemia
    • Aichi, Japan
      Novartis Investigative Site
    Dec 6, 2020

    Acute Myelogenous Leukemia Trial in Australia, Canada, United States (Decitabine, Vorinostat, Filgrastim (G-CSF))

    Completed
    • Acute Myelogenous Leukemia
    • Los Angeles, California
    • +32 more
    Jun 22, 2022

    Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive) Trial in Tokyo (Nilotinib)

    Completed
    • Chronic Myelogenous Leukemia
    • Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
    • Tokyo, Japan
      Novartis Investigative Site
    Dec 6, 2020

    Dual-target CAR-T Cells, B ALL, Relapse Trial in Shenzhen (Dual target CAR-T cell therapy)

    Unknown status
    • Dual-target CAR-T Cells
    • +3 more
    • Dual target CAR-T cell therapy
    • Shenzhen, Guangdong, China
      Shenzhen University General hospital
    Jan 23, 2021

    Relapsed B-cell Acute Lymphoblastic Leukemia, Refractory B-cell Acute Lymphoblastic Leukemia, Relapsed/Refractory B-cell

    Unknown status
    • Relapsed B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • BinD19
    • Zhengzhou, Henan, China
      The First Affiliated Hospital of Zhengzhou University
    Feb 3, 2021

    Relapsed B-cell Acute Lymphoblastic Leukemia, Childhood, Refractory B-cell Acute Lymphoblastic Leukemia, Childhood,

    Unknown status
    • Relapsed B-cell Acute Lymphoblastic Leukemia, Childhood
    • +2 more
    • BinD19
    • Shanghai, Shanghai, China
      Children's Hospital of Fudan University
    Feb 3, 2021